NanoTemper Technologies

04/05/2024

Our original global headquarters will always hold a special place in our hearts. Let’s take a look back at some of our favorite memories 📷 before we officially open our new office.

NanoTemper team, what’s your favorite memory at WerkStadt Sendling?

21/12/2023

Thank you to our customers and team for a memorable 2023! We wish you a joyous holiday season and a happy new year!

24/10/2023

Thank you to all the scientists who connected with us at ELRIG Drug Discovery! It was exciting to hear about your affinity screening projects and discuss ways to support them.

19/10/2023

Join this webinar to learn how to measure binding affinities with low sample consumption and no immobilization requirements using Spectral Shift — the go-to technology for in-solution measurements in countless buffers.

Register now: https://ow.ly/QqLp50PWh61

18/10/2023

Thank you to all the biologics scientists who visited us at Festival of Biologics in Basel! It was exciting to connect and chat about ways to support your biologics developability assessment and candidate selection projects.

17/10/2023

Antibody drug conjugates are leading a new era of targeted cancer therapy. However, there are unique concerns about their developbablity properties due to their the conjugation process, which makes it difficult to know which candidates to move forward with for further development.

Learn how to characterize multiple aspects of ADC stability in parallel to determine the impact of conjugation on your ADC’s developability.

Join webinar: https://ow.ly/qPCb50PWgVl

16/10/2023

Long interspersed nuclear element-1 (LINE-1) retrotransposition qualifies as a hallmark of cancer. Learn how Alexandra D'Ordine from Brown University, identifies small molecule inhibitors for a LINE-1 retrotransposon encoded endonuclease with Monolith X, an instrument with Spectral Shift technology.

Register today: https://ow.ly/Mams50PWgMY

10/10/2023

Accelerate your biologics candidate selection with the ability to measure affinities in solution from samples like crude lysate or cell media.

Learn how the new Human Fc labeling kit and Spectral Shift technology are simplifying affinity screening workflows.

NanoTemper Technologies, creator of high-quality, easy-to-learn biophysical tools for drug discovery, launches a new way for biologics researchers to

06/10/2023

Antibody Drug Conjugates (ADCs) are known as “biological missiles” leading a new era of targeted cancer therapy. Read this Nature review for valuable insights into the evolution of ADC drug development, how ADCs work, and the future outlook for the next generations of ADCs as therapeutics against cancer.

https://ow.ly/CZgh50PU5qf

05/10/2023

Festival of Biologics is coming up in Basel! Don’t miss Ping’s talk in the Protein Engineering track! She’ll share data from a case study that shows the importance of assessing both thermal and colloidal stability to choose the right constructs for optimal developability.

Stop by booth 1007 to chat more about biologics characterization!

04/10/2023

Thank you to everyone who visited us at Discovery on Target! It was exciting to meet so many scientists working towards removing the meaning of the word “undruggable." Thanks for connecting and chatting about ways to support your screening projects.